Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Multiple Dose Study Of PF-04950615 (RN316) In Subjects On Maximum Doses Of Statins

ClinicalTrials.gov ID: NCT01350141

Public ClinicalTrials.gov record NCT01350141. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 10:15 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Double-blind, Placebo-controlled, Randomized Study To Assess The Efficacy, Safety And Tolerability Of Pf-04950615 Following Multiple Intravenous Doses In Hypercholesterolemic Subjects On Maximum Dose Of Atorvastatin Or Rosuvastatin.

Study identification

NCT ID
NCT01350141
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
46 participants

Conditions and interventions

Interventions

  • Placebo Other
  • PF-04950615 (RN316) Drug

Other · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2011
Primary completion
Mar 31, 2012
Completion
May 31, 2012
Last update posted
Nov 7, 2017

2011 – 2012

United States locations

U.S. sites
29
U.S. states
14
U.S. cities
21
Facility City State ZIP Site status
Achieve Clinical Research, LLC Birmingham Alabama 35216
Advance Outcome Management, Inc. Garden Grove California 92845
Collaborative Neuroscience Network, Inc Garden Grove California 92845
Collaborative Neuroscience Network, Inc. Long Beach California 90806
Elite Clinical Trials, Inc. Wildomar California 92595
Innovative Research of West Florida, Inc. Clearwater Florida 33756
Avail Clinical Research, LLC DeLand Florida 32720
Kendall South Medical Center, Inc. Miami Florida 33185
Compass Research, LLC Orlando Florida 32806
Atlanta Diabetes Associates Atlanta Georgia 30309
Midwest Cardiology Associates Overland Park Kansas 66209
Stark Pharmacy Overland Park Kansas 66209
Vince and Associates Clinical Research Overland Park Kansas 66212
Saint Luke's Hospital Kansas City Missouri 64111
Saint Luke's Lipid and Diabetes Research Center Kansas City Missouri 64111
Advance Clinical Research St Louis Missouri 63128
Wake Internal Medicine Consultants, Inc. Raleigh North Carolina 27612
Wake Research Associates, LLC Raleigh North Carolina 27612
Lynn Health Science Institute Oklahoma City Oklahoma 73112
Oklahoma Cardiovascular Research Group Oklahoma City Oklahoma 73120
Oklahoma Heart Hospital Physicians Oklahoma City Oklahoma 73120
Oklahoma Heart Hospital Oklahoma City Oklahoma 73120
Altoona Center for Clinical Research Duncansville Pennsylvania 16635
DeGarmo Institute of Medical Research Greer South Carolina 29651
Holston Medical Group Kingsport Tennessee 37660
Texas Center for Drug Development, Inc Houston Texas 77081
Martin Diagnostic Clinic Tomball Texas 77375
Aspen Clinical Research, LLC Orem Utah 84058
National Clinical Research - Richmond, Inc. Richmond Virginia 23294

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01350141, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 7, 2017 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01350141 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →